A Safety Study of of AG-920 Sterile Topical Ophthalmic Solution
- First Posted Date
- 2022-08-16
- Last Posted Date
- 2024-10-09
- Lead Sponsor
- American Genomics, LLC
- Target Recruit Count
- 249
- Registration Number
- NCT05501860
- Locations
- 🇺🇸
American Genomics Site 1, Newport Beach, California, United States
🇺🇸American Genomics Site 2, McAllen, Texas, United States
A Study of Safety and the Local Anesthetic Effect of AG-920 Ophthalmic Solution in a Pediatric Population
- First Posted Date
- 2022-04-13
- Last Posted Date
- 2023-10-25
- Lead Sponsor
- American Genomics, LLC
- Target Recruit Count
- 61
- Registration Number
- NCT05325853
- Locations
- 🇺🇸
American Genomics Site 2, McAllen, Texas, United States
A Study of the Safety and Anesthetic Effect of AG-920 Topical Ophthalmic Solution
- First Posted Date
- 2021-04-02
- Last Posted Date
- 2024-10-10
- Lead Sponsor
- American Genomics, LLC
- Target Recruit Count
- 120
- Registration Number
- NCT04829344
- Locations
- 🇺🇸
American Genomics Site 2, McAllen, Texas, United States
An Open Label, Study of the Systemic Exposure to Articaine After Topical Ocular Dosing of AG-920
- First Posted Date
- 2021-02-18
- Last Posted Date
- 2022-04-29
- Lead Sponsor
- American Genomics, LLC
- Target Recruit Count
- 14
- Registration Number
- NCT04759339
- Locations
- 🇺🇸
Celerion, Lincoln, Nebraska, United States
A Study of the Safety and Anesthetic Effect of AG-920 Topical Ophthalmic Solution
- First Posted Date
- 2020-08-14
- Last Posted Date
- 2022-09-28
- Lead Sponsor
- American Genomics, LLC
- Target Recruit Count
- 120
- Registration Number
- NCT04513652
- Locations
- 🇺🇸
American Genomics Site 1, Newport Beach, California, United States
© Copyright 2025. All Rights Reserved by MedPath